Partnerships for prevention: Biopharma, patients, and digital technology
pharmaphorum
DECEMBER 7, 2023
Partnerships for prevention: Biopharma, patients, and digital technology Mike.Hammerton Thu, 07/12/2023 - 09:00 Bookmark this
pharmaphorum
DECEMBER 7, 2023
Partnerships for prevention: Biopharma, patients, and digital technology Mike.Hammerton Thu, 07/12/2023 - 09:00 Bookmark this
Drug Discovery World
OCTOBER 16, 2023
Alchemab, on the other hand, has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires, drawing from the expertise in Cambridge to progress the company’s mission to build a broad pipeline of protective therapeutics for hard-to-treat diseases.
XTalks
AUGUST 2, 2023
The acquisition of GBT, a biopharmaceutical company developing treatments to underserved patient communities, was completed in October 2022. In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. billion in 2022, a 23.43
Let's personalize your content